Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Lithium ions (Li + ) and nanohydroxyapatite (nHAp) doped with Li + enhance expression of late osteogenic markers in adipose-derived stem cells. Potential theranostic application of nHAp doped with Li + and co-doped with

Alicka M., Sobierajska P., Kornicka K., Wiglusz RJ., Marycz K.

Laboratory Study, published in Mater Sci Eng C Mater Biol Appl (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Sci Eng C Mater Biol Appl (2019)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
30889661
DOI
10.1016/j.msec.2019.02.073
Citations
19

Abstract (original English)

Lithium (Li + ) ion due to its excellent bioactivity is one of the most well-studied element in bone-tissue engineering. In this study, we fabricated nanohydroxyapatite (nHAp) doped with Li + ions (5 mol% Li + :nHAp) and co-doped with lanthanide ions. We investigated the effects of nHAp, 5 mol% Li + :nHAp or Li + alone, on osteogenic differentiation of human Adipose Tissue-derived Stem Cells (hASCs), their proliferation, mitochondrial dynamics and apoptosis. Moreover, we monitored cell proliferation after treatment with samarium (III) (Sm 3+ ) and europium (III) (Eu 3+ ) ions co-doped 5 mol% Li + :nHAp as well as their luminescent property. The hASCs treated with 5 mol% Li + :nHAp and Li + ions proliferated more rapidly and differentiated effectively than control cells without undergoing apoptosis. Both, 5 mol% Li + :nHAp and Li + ions improved osteogenic differentiation of hASCs. Moreover they decreased expression of glycogen synthase kinase 3β (GSK3β) while increased β-catenin mRNA level. In addition, Li + , nHAp and 5 mol% Li + :nHAp improved mitochondrial dynamics and enhanced expression of neural differentiation marker genes. Collectively, the study indicates on pro-osteogenic and anti-apoptotic properties of nHAp doped with Li + and Li + alone. Moreover, unique properties of 5 mol% Li + :nHAp and 5 mol% Li + :nHAp co-doped with rare earth ions, such as Sm 3+ and Eu 3+ hav

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ApoptosisBiomarkersCalcification, PhysiologicCalciumCell DifferentiationCell ProliferationCell SurvivalCytoskeletonDurapatiteEuropium

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.